NEPEXTO sol inj 25 mg/0.5ml ser pré 4 x 0.5 ml

7680681490012 CH-68149 L04AB01 07.15.0.

Reimbursement limitations:

NEPEXTO

Substitution préparation de référence/biosimilaire
Traitement par NEPEXTO exige une garantie préalable de prise en charge …

NEPEXTO sol inj 25 mg/0.5ml ser pré 4 x 0.5 ml
NEPEXTO sol inj 25 mg/0.5ml ser pré 4 x 0.5 ml
NEPEXTO sol inj 25 mg/0.5ml ser pré 4 x 0.5 ml
1 / 3
google

Details

Product number
6814902
CPT
-
Packaging group
4
Unit
Fertigspritze(n)
Composition
etanerceptum 25 mg, glycinum, natrii citras dihydricus, natrii dihydrogenophosphas dihydricus, saccharum, natrii chloridum, aqua ad iniectabile q.s. ad solutionem corresp. natrium 1.5 mg.

Articles (1)

Nepexto 25 mg/0.5 ml, Injektionslsöung in einer Fertigspritze
Fertigspritze
4
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
28/03/2025
Patient information leaflet
Français
28/03/2025
Patient information leaflet
Italien
28/03/2025
Professional SmPC
Allemand
28/03/2025
Professional SmPC
Français
28/03/2025
Professional SmPC
Italien
28/03/2025

Detailed composition

Substance Quantity Type Category
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.5 MG Substance HBESI

Reimbursement information

Public price
CHF 417.30
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/05/2025

Authorization holder

Medius AG

4132 Muttenz

Authorization information

Swissmedic authorization number
68149
Drug name
Nepexto, Injektionslösung in einer Fertigspritze
Galenic form
INLFS
ATC Code
L04AB01
Authorization status
Z
Dispensation category
B
First authorization
02/07/2021
Authorization expiration date
01/07/2026
IT number
07.15.0.
Domain
Human medicine
Field of application
Rheumatoide Arthritis, Psoriasis-Arthritis, Ankylosierende Spondylitis, Plaque-Psoriasis bei Erwachsenen sowie Kindern und Jugendlichen, Juvenile idiopatische Arthritis

Packaging details

Description (FR)
NEPEXTO sol inj 25 mg/0.5ml ser pré 4 x 0.5 ml
Description (DE)
NEPEXTO Inj Lös 25 mg/0.5ml Fertigspr 4 x 0.5 ml
Market launch
02/07/2021
Narcotic (BTM)
No

Other packaging sizes

NEPEXTO sol inj 50 mg/ml ser pré 4 x 1 ml
4 FESP
View
NEPEXTO sol inj 50 mg/ml ser pré 2 x 1 ml
2 FESP
View